Document Migration

PRODUCTS

  • Explore how to improve your process understanding with GoSilico™, a fast and reliable computer simulation. This Chromatography Modeling Software is a software designed for simulating preparative liquid chromatography processes with a computer to take you in silico.

  • PHCbi brand’s LabSVIFT® IoT lab management solution is designed to provide real-time visibility and control of laboratory equipment and environments across single or multiple facilities. This cloud-based platform enables centralized monitoring, customizable alerts, and secure data access via a web-based dashboard. The new health check* function continuously evaluates equipment performance, identifies irregularities, and provides recommended corrective actions to maintain optimal operation. The system supports FDA 21 CFR Part 11 compliance and is compatible with select PHCbi and third-party devices. *health check function compatibility varies by model

  • Eurofins PSS Insourcing Solutions is a strategic, compliant, and stable alternative to traditional staffing models, enabling biotech, pharmaceutical, and CDMO organizations to meet operational demands without increasing internal headcount or exposing themselves to co-employment risk. As a managed service provider, PSS hires, trains, and manages scientific personnel who perform defined scopes of work directly at client sites—fully integrated into client operations yet fully employed by Eurofins.

  • As a top Clinical Research Organization, ProPharma brings over 20 years of experience, innovation, personalization, and adaptability to Sponsors’ studies and research.

  • Accelerate your biomanufacturing capacity with purpose-built modules

    KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.

WHITE PAPERS AND CASE STUDIES

NEWS